SCHEMBL382491

SCHEMBL382491

CC(C)(C)C(N)[C@@](N)(C(=O)O)S(=O)(=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.42
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALDH1A1 P00352 2/20 0.37
NPC1 O15118 1/20 0.37
RECQL P46063 1/20 0.37
RAB9A P51151 1/20 0.37
SLC1A3 P43003 2/20 0.36
SLC1A2 P43004 2/20 0.36
SLC1A1 P43005 2/20 0.36
LARS1 Q9P2J5 1/20 0.36
PSIP1 O75475 1/20 0.36
CYP2C19 P33261 1/20 0.36
KYNU Q16719 2/20 0.36
MMP1 P03956 2/20 0.35
MMP2 P08253 2/20 0.35
MMP13 P45452 2/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6649064 0.75 HSD11B1 (0.46) HSD11B1CYP1A2CYP2D6ALDH1A1NPC1
SCHEMBL1464395 0.71 HSD11B1 (0.48) HSD11B1ALDH1A1NPC1RECQLRAB9A
SCHEMBL382489 0.71 SLC1A2 (0.40) HSD11B1CYP1A2CYP2D6ALDH1A1SLC1A3
SCHEMBL28442855 0.70 CA1 (0.48) HSD11B1ALDH1A1PSIP1MMP1MMP2
SCHEMBL28797596 0.70 MAPT (0.47) HSD11B1ALDH1A1NPC1RECQLRAB9A
SCHEMBL10604801 0.70 HSD11B1 (0.47) HSD11B1CYP1A2CYP2D6ALDH1A1NPC1
SCHEMBL27182773 0.69 HSD11B1 (0.43) HSD11B1CYP1A2CYP2D6ALDH1A1NPC1
SCHEMBL27388235 0.69 HSD11B1 (0.43) HSD11B1CYP1A2CYP2D6ALDH1A1NPC1
SCHEMBL5175906 0.69 ALDH1A1 (0.45) CYP1A2CYP2D6ALDH1A1RECQLSLC1A3
SCHEMBL9188767 0.69 ALDH1A1 (0.41) ALDH1A1RECQLRAB9ASLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 EP disclosed